Compounded or brand GLP-1Coaching + medication

Ivim Health review

Name: Ivim Health review
Item: Ivim Health
Rating: 3.7

Ivim Health is best for eligible adults who want provider access and coaching alongside compounded or insurance-supported brand-name GLP-1 treatment, with the main trade-off being a required membership plus multi-month medication commitments and inconsistent advertised pricing.

3.7/5

How we score

Updated Jul 13, 2026

Published starting price

First monthMonthly

Not verified

Lowest advertised starting total · $149.99/moBuilt from a $75 compounded semaglutide headline plus a $74.99 program fee; longer commitment appears required.Checked Jul 13, 2026
Membership · $74.99–$75/moThe first month is advertised as free on the pricing page; membership covers care services rather than every medication cost.Checked Jul 13, 2026
Compounded options · Semaglutide and tirzepatide injectionsThese are prescription compounded products, not FDA-approved Wegovy, Ozempic, Zepbound, or Mounjaro.Checked Jul 13, 2026
Brand pathway · FDA-approved brands may be prescribedIvim discusses Wegovy and Zepbound access and insurance prior-authorization support; its site also discusses Ozempic, Mounjaro, Saxenda, and other GLP-1 drugs.Checked Jul 13, 2026

Source: Ivim Health GLP-1 pricing · Checked Jul 13, 2026

Check this: Checked over 30 days ago.

Confirm the price at checkout.

Visit Ivim Health Partner link

Good for

Patients who want unlimited virtual provider visits and ongoing care-team access rather than a prescription-only service.
Self-pay patients willing to consider compounded semaglutide or tirzepatide after an individualized clinical evaluation.
People who can handle an upfront multi-month medication purchase and a separate ongoing membership fee after the introductory month—not simply month-to-month medication billing after that point, and not necessarily the full membership commitment disclosed at checkout—with exact timing to verify before purchase given the different public offers and term lengths found on Ivim’s site. Additionally, people who want insurance prior-authorization assistance for an FDA-approved brand such as Wegovy or Zepbound, understanding that approval, availability, and out-of-pocket cost are not guaranteed.

Skip if

Ivim’s compounded semaglutide and tirzepatide products are not FDA-approved; FDA does not review compounded products for safety, effectiveness, or quality before marketing.
Public Ivim pages show conflicting starting prices and program configurations, so the checkout total, term, dose-dependent charges, and renewal schedule require confirmation.
The membership fee is separate from some advertised medication prices and continues after the free first month unless canceled under the applicable terms, while an active membership is required for medication-program access and continuation, subject to the specific program terms at checkout. Since medication-program purchases may be non-refundable and cancellation may not unwind a started multi-month commitment, confirm those terms before payment rather than assuming a simple month-to-month arrangement. Ivim’s terms also define a month as 28 days, which affects how multi-month program lengths are counted. The public pages reviewed show different $74.99 versus $75 membership wording, so verify the exact recurring amount and the first billing date on the final order screen. Do not rely only on a marketing-page monthly equivalent when assessing cash flow, because several offers require full multi-month payment upfront. Confirm whether future medication shipments require additional action, what happens if treatment is paused by the clinician, and whether unused program time can lapse, as the terms describe program periods and grace periods. Any refund exception should be obtained in writing if it materially affects the purchase decision. This is especially important when comparing Ivim with services that genuinely bill medication one month at a time. The same caution applies to discount or promotional offers, which Ivim says can change or end without notice and may not be combined. Finally, save a dated copy or screenshot of the checkout terms so later renewals can be compared with what was accepted at enrollment. In short, treat the advertised monthly number as a starting calculation, not a guaranteed universally available month-to-month price. Current program terms, eligibility, and clinical decisions ultimately control. Pricing transparency is therefore moderate rather than complete, despite several published figures. Verify all charges before authorizing payment, including taxes, shipping if any, labs if requested, insurance copays, and membership renewal. The official pages reviewed say medication delivery and clinical services are included in the described compounded packages, but exact inclusions can vary by product, subscription, and commitment. Ask support to itemize the medication amount, membership amount, upfront charge, future recurring charges, and cancellation deadline in one written response. This will produce a more reliable comparison than dividing a promotional total by its advertised number of months. Do not assume that a free consultation means treatment or medication is free.

3 things to know

Ivim’s compounded semaglutide and tirzepatide products are not FDA-approved; FDA does not review compounded products for safety, effectiveness, or quality before marketing.
Public Ivim pages show conflicting starting prices and program configurations, so the checkout total, term, dose-dependent charges, and renewal schedule require confirmation.
The membership fee is separate from some advertised medication prices and continues after the free first month unless canceled under the applicable terms, while an active membership is required for medication-program access and continuation, subject to the specific program terms at checkout. Since medication-program purchases may be non-refundable and cancellation may not unwind a started multi-month commitment, confirm those terms before payment rather than assuming a simple month-to-month arrangement. Ivim’s terms also define a month as 28 days, which affects how multi-month program lengths are counted. The public pages reviewed show different $74.99 versus $75 membership wording, so verify the exact recurring amount and the first billing date on the final order screen. Do not rely only on a marketing-page monthly equivalent when assessing cash flow, because several offers require full multi-month payment upfront. Confirm whether future medication shipments require additional action, what happens if treatment is paused by the clinician, and whether unused program time can lapse, as the terms describe program periods and grace periods. Any refund exception should be obtained in writing if it materially affects the purchase decision. This is especially important when comparing Ivim with services that genuinely bill medication one month at a time. The same caution applies to discount or promotional offers, which Ivim says can change or end without notice and may not be combined. Finally, save a dated copy or screenshot of the checkout terms so later renewals can be compared with what was accepted at enrollment. In short, treat the advertised monthly number as a starting calculation, not a guaranteed universally available month-to-month price. Current program terms, eligibility, and clinical decisions ultimately control. Pricing transparency is therefore moderate rather than complete, despite several published figures. Verify all charges before authorizing payment, including taxes, shipping if any, labs if requested, insurance copays, and membership renewal. The official pages reviewed say medication delivery and clinical services are included in the described compounded packages, but exact inclusions can vary by product, subscription, and commitment. Ask support to itemize the medication amount, membership amount, upfront charge, future recurring charges, and cancellation deadline in one written response. This will produce a more reliable comparison than dividing a promotional total by its advertised number of months. Do not assume that a free consultation means treatment or medication is free.

Ask at your intake visit

Recheck whether $75 medication plus a $74.99 program fee remains the lowest available combined offer and whether it is limited to a six-month or microdosing/GLP-1 ID plan.
Reconcile the homepage’s $75 semaglutide headline with the separate pricing page’s $600 six-month package and any other semaglutide starting prices.
Confirm whether the first membership month is free for the exact selected program and whether the ongoing charge is $74.99 or $75.
Confirm whether the full medication term is prepaid, the precise refund and cancellation rules, and how unused program value is handled if a clinician pauses or stops treatment given the selected product, subscription, commitment, and clinical circumstances—including Ivim’s 28-day definition of a program month and any applicable grace period or provider-authorized timeline adjustment under the current terms. A personalized checkout agreement may differ from general marketing pages, so the reader should obtain the controlling terms in writing before payment. Also verify whether an active membership must remain in place for the entire medication period and whether canceling membership affects already-paid shipments, clinical follow-up, prescription access, or unused program time. Confirm any exceptions for medical ineligibility discovered after purchase, adverse effects, pregnancy, shipping failures, pharmacy inability to dispense, or changes in state eligibility. The public terms describe limited exceptions and clinical discretion but should not be summarized as a guaranteed refund. Check the current Refund and Returns Policy alongside the Terms and Conditions because policies may change independently.

Nearby options

All comparison pages

4.3

Ro

From$149/mo

Source: Ro pricing page · Checked Jul 6, 2026

Checked Jul 6, 2026 · confirm at checkout

Visit Partner link

4.2

Hims + Hers

From$149/mo

Source: Hims weight loss page · Checked Jul 6, 2026

Checked Jul 6, 2026 · confirm at checkout

Visit Partner link

4.1

TrimRx

From$199/mo

Source: TrimRx homepage · Checked Jul 6, 2026

Checked Jul 6, 2026 · confirm at checkout

Visit Partner link

Educational content only. Do not use this page as medical advice or as a substitute for a licensed clinician, pharmacist or insurer reviewing your situation.

Sources: Ivim Health GLP-1 pricing Ivim Health homepage pricing Ivim compounded-medication overview Ivim terms and conditions Ivim state-specific program notice Ivim California scheduling page Ivim Zepbound program pageChecked Jul 13, 2026

Read the full review

Price snapshot

Published price

From $149.99/mo

Source: Ivim Health GLP-1 pricing

What to verify

Recheck whether $75 medication plus a $74.99 program fee remains the lowest available combined offer and whether it is limited to a six-month or microdosing/GLP-1 ID plan.
Reconcile the homepage’s $75 semaglutide headline with the separate pricing page’s $600 six-month package and any other semaglutide starting prices.
Confirm whether the first membership month is free for the exact selected program and whether the ongoing charge is $74.99 or $75.
Confirm whether the full medication term is prepaid, the precise refund and cancellation rules, and how unused program value is handled if a clinician pauses or stops treatment given the selected product, subscription, commitment, and clinical circumstances—including Ivim’s 28-day definition of a program month and any applicable grace period or provider-authorized timeline adjustment under the current terms. A personalized checkout agreement may differ from general marketing pages, so the reader should obtain the controlling terms in writing before payment. Also verify whether an active membership must remain in place for the entire medication period and whether canceling membership affects already-paid shipments, clinical follow-up, prescription access, or unused program time. Confirm any exceptions for medical ineligibility discovered after purchase, adverse effects, pregnancy, shipping failures, pharmacy inability to dispense, or changes in state eligibility. The public terms describe limited exceptions and clinical discretion but should not be summarized as a guaranteed refund. Check the current Refund and Returns Policy alongside the Terms and Conditions because policies may change independently.

Review overview

Last checked Jul 5, 2026

Best fit

Patients who want unlimited virtual provider visits and ongoing care-team access rather than a prescription-only service.
Self-pay patients willing to consider compounded semaglutide or tirzepatide after an individualized clinical evaluation.
People who can handle an upfront multi-month medication purchase and a separate ongoing membership fee after the introductory month—not simply month-to-month medication billing after that point, and not necessarily the full membership commitment disclosed at checkout—with exact timing to verify before purchase given the different public offers and term lengths found on Ivim’s site. Additionally, people who want insurance prior-authorization assistance for an FDA-approved brand such as Wegovy or Zepbound, understanding that approval, availability, and out-of-pocket cost are not guaranteed.

Watch-outs

Ivim’s compounded semaglutide and tirzepatide products are not FDA-approved; FDA does not review compounded products for safety, effectiveness, or quality before marketing.
Public Ivim pages show conflicting starting prices and program configurations, so the checkout total, term, dose-dependent charges, and renewal schedule require confirmation.
The membership fee is separate from some advertised medication prices and continues after the free first month unless canceled under the applicable terms, while an active membership is required for medication-program access and continuation, subject to the specific program terms at checkout. Since medication-program purchases may be non-refundable and cancellation may not unwind a started multi-month commitment, confirm those terms before payment rather than assuming a simple month-to-month arrangement. Ivim’s terms also define a month as 28 days, which affects how multi-month program lengths are counted. The public pages reviewed show different $74.99 versus $75 membership wording, so verify the exact recurring amount and the first billing date on the final order screen. Do not rely only on a marketing-page monthly equivalent when assessing cash flow, because several offers require full multi-month payment upfront. Confirm whether future medication shipments require additional action, what happens if treatment is paused by the clinician, and whether unused program time can lapse, as the terms describe program periods and grace periods. Any refund exception should be obtained in writing if it materially affects the purchase decision. This is especially important when comparing Ivim with services that genuinely bill medication one month at a time. The same caution applies to discount or promotional offers, which Ivim says can change or end without notice and may not be combined. Finally, save a dated copy or screenshot of the checkout terms so later renewals can be compared with what was accepted at enrollment. In short, treat the advertised monthly number as a starting calculation, not a guaranteed universally available month-to-month price. Current program terms, eligibility, and clinical decisions ultimately control. Pricing transparency is therefore moderate rather than complete, despite several published figures. Verify all charges before authorizing payment, including taxes, shipping if any, labs if requested, insurance copays, and membership renewal. The official pages reviewed say medication delivery and clinical services are included in the described compounded packages, but exact inclusions can vary by product, subscription, and commitment. Ask support to itemize the medication amount, membership amount, upfront charge, future recurring charges, and cancellation deadline in one written response. This will produce a more reliable comparison than dividing a promotional total by its advertised number of months. Do not assume that a free consultation means treatment or medication is free.

Price snapshot: From $149.99/mo

Official source

CravingWise verdict

3.7/5

How we score

CravingWise verdict

Last checked Jul 5, 2026

From

$149.99/moMeds vary by plan

Cost calculator

Best fit

Patients who want unlimited virtual provider visits and ongoing care-team access rather than a prescription-only service.
Self-pay patients willing to consider compounded semaglutide or tirzepatide after an individualized clinical evaluation.
People who can handle an upfront multi-month medication purchase and a separate ongoing membership fee after the introductory month—not simply month-to-month medication billing after that point, and not necessarily the full membership commitment disclosed at checkout—with exact timing to verify before purchase given the different public offers and term lengths found on Ivim’s site. Additionally, people who want insurance prior-authorization assistance for an FDA-approved brand such as Wegovy or Zepbound, understanding that approval, availability, and out-of-pocket cost are not guaranteed.

Verify before paying

Ivim’s compounded semaglutide and tirzepatide products are not FDA-approved; FDA does not review compounded products for safety, effectiveness, or quality before marketing.
Public Ivim pages show conflicting starting prices and program configurations, so the checkout total, term, dose-dependent charges, and renewal schedule require confirmation.
The membership fee is separate from some advertised medication prices and continues after the free first month unless canceled under the applicable terms, while an active membership is required for medication-program access and continuation, subject to the specific program terms at checkout. Since medication-program purchases may be non-refundable and cancellation may not unwind a started multi-month commitment, confirm those terms before payment rather than assuming a simple month-to-month arrangement. Ivim’s terms also define a month as 28 days, which affects how multi-month program lengths are counted. The public pages reviewed show different $74.99 versus $75 membership wording, so verify the exact recurring amount and the first billing date on the final order screen. Do not rely only on a marketing-page monthly equivalent when assessing cash flow, because several offers require full multi-month payment upfront. Confirm whether future medication shipments require additional action, what happens if treatment is paused by the clinician, and whether unused program time can lapse, as the terms describe program periods and grace periods. Any refund exception should be obtained in writing if it materially affects the purchase decision. This is especially important when comparing Ivim with services that genuinely bill medication one month at a time. The same caution applies to discount or promotional offers, which Ivim says can change or end without notice and may not be combined. Finally, save a dated copy or screenshot of the checkout terms so later renewals can be compared with what was accepted at enrollment. In short, treat the advertised monthly number as a starting calculation, not a guaranteed universally available month-to-month price. Current program terms, eligibility, and clinical decisions ultimately control. Pricing transparency is therefore moderate rather than complete, despite several published figures. Verify all charges before authorizing payment, including taxes, shipping if any, labs if requested, insurance copays, and membership renewal. The official pages reviewed say medication delivery and clinical services are included in the described compounded packages, but exact inclusions can vary by product, subscription, and commitment. Ask support to itemize the medication amount, membership amount, upfront charge, future recurring charges, and cancellation deadline in one written response. This will produce a more reliable comparison than dividing a promotional total by its advertised number of months. Do not assume that a free consultation means treatment or medication is free.

Lowest advertised starting total: $149.99/mo
Membership: $74.99–$75/mo
Compounded options: Semaglutide and tirzepatide injections
Last checked: July 13, 2026

Pricing and what is included

Ivim separates the medication program from an ongoing care membership. Its homepage advertises compounded semaglutide from $75 per month and compounded tirzepatide from $133 per month, plus a $74.99 monthly program fee. That creates a lowest advertised starting combination of $149.99 per month, but the offer appears tied to a longer commitment. A separate pricing page shows different package figures: semaglutide costs $379 for two months, $499 for four months, or $600 for six months; tirzepatide costs $550, $900, or $1,100 for the same terms. That page says the first membership month is free and membership is $75 monthly afterward. It also warns that the actual price depends on the product, subscription, and commitment. The compounded package includes the medication, delivery, provider visits, refills or adjustments, coaching, and clinical support as described by Ivim. Brand-name medication costs are different: insurance coverage, copays, cash pricing, and pharmacy availability can determine the final amount. Because the public pages do not reconcile every advertised figure, use $149.99 only as a starting monthly equivalent. Confirm the amount due immediately, future membership charges, refund rules, and complete program cost at checkout.

Lowest advertised combined starting figure: $149.99 per month.
Multi-month medication charges may be collected upfront.
Brand medication and insurance costs are not established by the compounded-package prices.

Medication model: FDA-approved brands versus compounded products

Ivim’s clearly priced self-pay offering centers on compounded injectable semaglutide and compounded injectable tirzepatide. These products are not FDA-approved, even though their active ingredients also appear in approved brand medications. They should not be described as generic Wegovy, Ozempic, Zepbound, or Mounjaro. Ivim says prescriptions are individualized and filled by independent, state-licensed compounding pharmacies after a medical evaluation. FDA states that compounded drugs do not receive its premarket review for safety, effectiveness, or quality and generally should be used when a patient’s medical needs cannot be met by an approved product. Ivim also supports access to brand-name drugs. Its program pages discuss Wegovy and Zepbound, which have FDA-approved weight-management indications, along with Ozempic, Mounjaro, Saxenda, and other GLP-1 products. The exact drug and whether its use is FDA-labeled or off-label must be confirmed with the prescriber; simply appearing on Ivim’s website does not guarantee access. Regulatory context matters in 2026: FDA reported in April that semaglutide and tirzepatide were not on its shortage list or the 503B bulks list. Individual-patient compounding may involve other statutory conditions, so editors and patients should re-check the current status and the pharmacy’s basis for dispensing before relying on availability.

Compounded semaglutide and tirzepatide: not FDA-approved.
Wegovy and Zepbound: FDA-approved branded weight-management products discussed by Ivim.
Eligibility and access depend on clinical judgment, state law, insurance, and pharmacy availability.

Pricing ledger

Price Ivim Health as line items, not a headline

These are the public pricing claims and checkout questions that decide whether the offer is actually comparable.

Lowest advertised starting total$149.99/mo

Built from a $75 compounded semaglutide headline plus a $74.99 program fee; longer commitment appears required.

Confirm availability, amount due today, 28-day versus calendar-month billing, and renewal terms at checkout.

Membership$74.99–$75/mo

The first month is advertised as free on the pricing page; membership covers care services rather than every medication cost.

Confirm the first charge date, cancellation deadline, and whether membership continues beyond the medication term.

Compounded optionsSemaglutide and tirzepatide injections

These are prescription compounded products, not FDA-approved Wegovy, Ozempic, Zepbound, or Mounjaro.

Ask for the dispensing pharmacy, exact formulation, state license, and current basis for compounding.

Brand pathwayFDA-approved brands may be prescribed

Ivim discusses Wegovy and Zepbound access and insurance prior-authorization support; its site also discusses Ozempic, Mounjaro, Saxenda, and other GLP-1 drugs.

Confirm the exact labeled or off-label use, insurance coverage, pharmacy price, stock, and whether the brand is guaranteed—because Ivim says it is not.

Source: Ivim Health GLP-1 pricing · Checked Jul 13, 2026

Checked Jul 13, 2026 · confirm at checkout

Clinician evaluation and follow-up

The program begins with an intake questionnaire and an advertised free initial provider consultation. A licensed Ivim provider evaluates eligibility and retains clinical discretion over whether to prescribe, which product to use, and whether treatment should continue. Paying for membership or entering a program therefore does not guarantee a prescription. The $74.99–$75 membership is presented as the care layer. Ivim says it includes unlimited virtual provider visits, medication management, health coaching, app-based progress tracking, community resources, and 24/7 access to the clinical team by text or phone. The pricing page also advertises weekly adjustments and a personalized treatment schedule, although the actual frequency of synchronous visits should be confirmed for the individual plan. Ivim’s current terms provide a more specific continuation requirement: medication is generally dispensed in no more than two 28-day increments, and continued shipment depends on a required clinical follow-up, typically around the eighth week. That follow-up may occur through telehealth or an online health assessment and is included without an additional visit fee. Failure to complete it can delay or stop later shipments. For brand medications, membership also includes care coordination and prior-authorization assistance, but the terms state that a denial or delay by an insurer does not make the membership fee refundable.

Prescription only after clinical evaluation.
Unlimited visits and care-team access are advertised with membership.
A follow-up around week eight may be required before additional medication ships.

The check we would not skip

Ivim’s compounded semaglutide and tirzepatide products are not FDA-approved; FDA does not review compounded products for safety, effectiveness, or quality before marketing.

The check we would not skip · CravingWise research desk

What to verify before paying

Start by requesting an itemized quote showing the medication charge, membership charge, amount due immediately, future renewal dates, program duration, and cancellation or refund terms. Ivim defines a program month as 28 days, so a four-month program is 16 weeks rather than four calendar months. Its terms also say medication-program purchases are generally non-refundable outside stated exceptions. Next, confirm whether the prescription would be an FDA-approved brand or a compounded preparation. For a compounded product, ask for the dispensing pharmacy’s name, state-license details, exact formulation, concentration, and any available quality documentation. FDA recommends obtaining compounded GLP-1 drugs through a licensed prescriber and state-licensed pharmacy and warns about dosing errors, inadequate refrigeration, fraudulent labels, and semaglutide salt forms. State availability also needs direct confirmation. Ivim’s general disclaimer says compounded programs are not available in all states, an official page excludes its accessibility program in Mississippi, and its California scheduling page says California patients are limited to Jump Start packages with an initial three-month commitment. No complete current state-by-state list was found. For a brand prescription, verify insurance criteria, prior-authorization status, copay, pharmacy stock, and whether the prescribed use is FDA-labeled. Recheck everything on the final checkout screen because Ivim says offers can change without notice.

Get the complete written price and commitment before authorizing payment.
Verify the exact product and dispensing pharmacy—not only the active ingredient.
Confirm eligibility for the patient’s state and physical location during telehealth care.

Who Ivim fits—and who may prefer another provider

Ivim is a plausible fit for eligible adults who want more support than a medication-only telehealth service. The membership bundles provider access, coaching, tracking tools, community resources, and ongoing prescription management. It may also appeal to people who want one service that can discuss both compounded self-pay treatment and insurance-supported access to an FDA-approved brand. Its published multi-month compounded prices can be easier to estimate than an entirely unpublished program, provided the patient can handle the upfront payment and verifies which promotion applies. It is a weaker fit for someone seeking a simple month-to-month medication bill with no separate membership. It may also be unsuitable for people unwilling to use a non-FDA-approved compounded product unless Ivim and their insurer can secure the specific approved brand they want. Those needing a guaranteed medication, guaranteed insurance approval, or a universally published cash price for brands will not receive those assurances from the public materials reviewed. State restrictions and California-specific commitments can further narrow availability. Finally, the terms around non-refundable medication purchases and required follow-up deserve attention from anyone who values easy cancellation. The practical decision should rest on three written answers: the exact dispensed product, the all-in cost for the full commitment, and confirmation that both the clinician and dispensing pharmacy can legally serve the patient’s state.

Good fit: people who value frequent clinician access and coaching.
Potential mismatch: medication-only shoppers or those requiring simple monthly cancellation.
Potential mismatch: anyone who will accept only an FDA-approved brand without first confirming coverage and supply.

Nearby options

Side-by-side

Compare Ivim Health against nearby options

Use this as a shortlist, not a final ranking. The right choice still depends on your quote, medication route, insurance result and follow-up needs. All comparison pages.

Provider	Advertised cost	Medication path
Ivim HealthCurrent review · Score 3.7/5	From $149.99/mo Source: Ivim Health GLP-1 pricing · Checked Jul 13, 2026 Checked Jul 13, 2026 · confirm at checkout	Compounded or brand GLP-1
TrimRxScore 4.1/5	From $199/mo Source: TrimRx homepage · Checked Jul 6, 2026 Checked Jul 6, 2026 · confirm at checkout	Compounded GLP-1
Hims + HersScore 4.2/5	From $149/mo meds + membership Source: Hims weight loss page · Checked Jul 6, 2026 Checked Jul 6, 2026 · confirm at checkout	FDA-approved brand paths
RoScore 4.3/5	$39 first month; meds separate Source: Ro pricing page · Checked Jul 6, 2026 Checked Jul 6, 2026 · confirm at checkout	Brand GLP-1 + insurance support

Educational content only. Do not use this page as medical advice or as a substitute for a licensed clinician, pharmacist or insurer reviewing your situation.

Related checks

Sources and what to verify (7)

Sources

Ivim Health GLP-1 pricing
Official compounded-package prices, membership fee, included services, and first-month promotion.
Ivim Health homepage pricing
Official $75 semaglutide and $133 tirzepatide starting figures plus the $74.99 program fee.
Ivim compounded-medication overview
Official explanation of individualized compounded products, insurance treatment, prescribing, and pharmacy model.
Ivim terms and conditions
Official membership requirement, 28-day program months, follow-up requirements, clinical discretion, refunds, and prior-authorization terms.
Ivim state-specific program notice
Official notice that the accessibility program is unavailable in Mississippi and that compounded products are not available in every state.
Ivim California scheduling page
Official California limitation to Jump Start packages with an initial three-month commitment.
Ivim Zepbound program page
Official description of potential branded Zepbound access and dependence on clinical eligibility and insurance.